. 2012 Apr;22(4):369–376. doi: 10.1089/thy.2011.0198

Table 2.

Study Procedures

	RAI-L-ABL group		C-Tx group		T-Tx group
Steps	Procedure	n^a	Procedure	n^a	Procedure	n^a
Step 1	Hemithyroidectomy	37/37	Hemithyroidectomy	68/68	T-Tx	29/29
Step 2	Thyroid lobe ablation (30–32 mCi ¹³¹I)	37/37	C-Tx	68/73	—
Step 3	WBS (2 mCi ¹³¹I), Tg, TSH in hypothyroidism	36/37	WBS (2 mCi ¹³¹I), Tg, TSH in hypothyroidism	58/68	WBS (2 mCi ¹³¹I), Tg, TSH in hypothyroidism	25/29
Step 4	Remnant ablation (30–150 mCi ¹³¹I)	15/37	Remnant ablation (30–150 mCi ¹³¹I)	58/68	Remnant ablation (30–150 mCi ¹³¹I)	12/29
Step 5	Stimulated Tg	12/37	Stimulated Tg	26/68	Stimulated Tg	12/29
Step 6	Unstimulated Tg, clinical restaging at the end of follow-up	37/37	Unstimulated Tg, clinical restaging at the end of follow-up	68/68	Unstimulated Tg, clinical restaging at the end of follow-up	29/29

Study procedures are described in their temporal sequence. All patients in all the RAI-L-ABL and C-Tx groups underwent Steps 1, 2, and 6. All patients in the T-Tx group underwent Steps 1 and 6.

^{^a}

Number of patients undergoing each step.

WBS, whole body scanning; Tg, thyroglobulin; TSH, thyroid-stimulating hormone.